EPD Shorts Tick Up, But the Story Is Still Fundamentals
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Enterprise Products Partners reports Q3 2026 results on October 29 with short interest nudging higher but still far too small to shape the outcome, leaving the quarter's debate squarely on NGL margins and distribution coverage.
Short interest rose about 6.5% in the latest session to 18.6 million shares, unwinding some of the decline noted earlier this month. Even so, it represents just 0.86% of the free float, a level that carries no real directional weight. The borrow market is consistent with that reading: cost to borrow is 0.42%, and availability remains at 477%, roughly five shares available to lend for every one already out on loan. That is a loose market with no squeeze dynamic in play. The put/call ratio of 0.27 is fractionally below its 20-day average of 0.28, with call activity continuing to run ahead of puts. The stock itself closed at $37.17, up just 0.5% on the week, lagging the median weekly gain of closer to 2.8% across its closest midstream peers. ET added 4.4% on the week, PAA rose 3.6%, and OKE gained 3.4%, all outpacing EPD's more measured move.
The fundamental debate centres on how much the revised EBITDA outlook matters relative to the partnership's structural strengths. Bears point to a 3Q26 Adjusted EBITDA estimate of $2,689 million, trimmed from $2,748 million previously, with PDH2 downtime and margin normalisation in NGL, crude and natural gas each contributing to the revision. Weaker commodity prices or a broader pullback in drilling activity could squeeze processing margins further, and project execution risk is a persistent concern given the scale of EPD's capital programme. The bull case rests on the durability of the fee-based franchise: strong export demand, roughly 90% contracted LPG dock capacity, and an organic growth backlog that management expects to lift earnings into 2027. Distribution coverage estimated above 1.5x and leverage in the 2.75x to 3.25x range underpin the income argument. Analyst sentiment is cautious rather than negative, with a consensus price target around $41, implying roughly 10% above current levels, though JP Morgan trimmed its target to $42 from $43 in early October while keeping a Neutral rating.
The ownership structure is worth noting. Randa Duncan Williams filed a Schedule 13D amendment on October 2, disclosing a stake of 32.6%, up from 32.4%, at roughly 702.6 million shares. Enterprise Products Company itself holds a further 31.5% of shares. Stakes at that scale are as-last-disclosed and subject to the usual 13D/G caveats, but the concentrated insider ownership has historically dampened short-side conviction, consistent with the low float short interest seen today.
The Q3 print will test whether the PDH2 disruption and NGL margin headwinds were contained to one quarter, or whether the revised full-year EBITDA range marks the beginning of a softer trend into 2027.
Stocks in this article
See the live data behind this article on ORTEX.
Open EPD on ORTEX →How this article was generated
- Generated
- 28 Oct 2026, 04:04
- Data as of
- 28 Oct 2026, 04:00
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.